Is Agen (Agen) a good stock to buy?

AGEN has a Quality Grade of C, ranking ahead of 55.26% of graded US stocks. AGEN's asset turnover comes in at 0.324 -- ranking 139th of 681 Pharmaceutical Products stocks. COCP, MTEM, and LGND are the stocks whose asset turnover ratios are most correlated with AGEN. The table below shows AGEN's key quality metrics over time.

What time is Agenus' annual shareholders meeting 2024?

Currency in USD LEXINGTON, Mass., June 04, 2024--Agenus Inc. ("Agenus") (NASDAQ: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced that its Annual Shareholders Meeting will begin at 10:30 a.m. ET on June 11, 2024, and will be conducted in a virtual format only.

Does Agenus comply with Nasdaq Listing Rule 5550(a)(2)?

LEXINGTON, Mass., May 01, 2024--Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in immunology-based therapies for cancer, received notice from NASDAQ on April 30, 2024, that the Company has regained compliance with the $1.00 minimum bid price requirement set forth in NASDAQ Listing Rule 5550 (a) (2).

The World's Leading Crypto Trading Platform

Get my welcome gifts